Airway hyper-responsiveness associated with asthma is mediated by airway smooth muscle cells (SMCs) and has a complicated etiology involving increases in cell contraction and proliferation and the secretion of inflammatory mediators. Although these pathological changes are diverse, a common feature associated with their regulation is a change in intracellular Ca 2+ concentration ([Ca 2+ ] i ). Because the [Ca 2+ ] i itself is a function of the activity and expression of a variety of ion channels, in both the plasma membrane and sarcoplasmic reticulum of the SMC, the modification of this ion channel activity may predispose airway SMCs to hyper-responsiveness. Our objective is to review how ion channels determine the [Ca 2+ ] i and influence the function of airway SMCs and emphasize the potential of ion channels as sites for therapeutic approaches to asthma.
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Asthma-associated airway hyper-responsiveness (AHR) is primarily mediated by excessive airway smooth muscle cell (SMC) contraction, yet the mechanisms responsible for this behavior remain unknown. A hypothesis commonly favored to explain excessive force production by individual SMCs is that the intracellular calcium concentration ([Ca 2+ ] i ) that regulates SMC contraction is abnormally elevated in asthmatic airway SMCs. However, in view of the importance of Ca 2+ as a second messenger, an elevated [Ca 2+ ] i would have other wide-ranging ramifications for SMC physiology and this may be expressed in terms of altered cell proliferation or phenotype. SMC contraction is also determined by the sensitivity of the SMC contractile apparatus to the [Ca 2+ ] i and AHR may be explained by an abnormal increase in Ca 2+ sensitivity. Similarly, airway constriction also depends on the number and size of the SMCs and the resistive load experienced by these SMCs. As a result, increased SMC proliferation and airway wall remodeling, processes commonly associated with airway inflammation, are believed to significantly contribute to AHR. A common theme linking these varied processes is that each one is regulated or influenced by [Ca 2+ ] i which, in turn, is determined by the activity of a wide variety of ion channels, in balance with membrane Ca 2+ pumps. This increase in [Ca 2+ ] i can be achieved in two fundamental ways; by the release of Ca 2+ from internal stores via specialized receptor/channels on the sarcoplasmic reticulum or by Ca 2+ influx from the extracellular space via a variety of plasma membrane ion channels. The objective of this review is to focus on the nature of this channel activity and how it relates to changes in [Ca 2+ ] i and the regulation of SMC contraction, proliferation and secretion, with the idea that ion channels may serve as therapeutic targets for AHR.
Mechanisms of internal Ca 2+ release
Agonist-induced SMC contraction is predominately dependent on increases in [Ca 2+ ] i resulting from the release of Ca 2+ from internal stores, namely the sarcoplasmic reticulum. Importantly, oscillations [2, 3] . Agonist-induced Ca 2+ oscillations (using ACh or 5HT) occur in tracheal, bronchial and small airways of mice [1, [4] [5] [6] , pigs [2, 7, 8] , and humans [9] . Importantly, the frequency of these Ca 2+ oscillations generally increases with the concentration of the agonist [1, 5, 10] ] i , exposure to equal concentrations of different agonists (e.g. methacholine or 5HT) resulted in different amounts of contraction [20, 21] . These observations indicate that, in addition to the frequency of Ca 2+ oscillations, the Ca 2+ sensitivity of SMCs is a major factor contributing to the regulation of SMC contraction [22] . With this insight into airway SMC contraction, we can turn our attention to the important mechanism of broncho-dilation that must be acutely induced to counter AHR occurring during an asthma attack. Over the longer term, the therapeutic aim is the prevention of AHR. These goals require the relaxation and desensitization of the airway SMCs. A current primary approach used to relax airway SMCs is the inhalation of b 2 -agonists that mediate their effects via increases in cAMP and the activation on protein kinase A [18, 23] . However the mechanism of SMC relaxation is not well understood. Activation of b 2 -receptors with agonists, such as, salbutamol [24] , isoproterenol [18] and albuterol [23] Over the long term, it is not clear how the SMCs become hyperresponsive, but stimulation of the mechanisms of Ca 2+ release and re-uptake could result in an increase in the frequency of agonistinduced Ca 2+ oscillations which, in turn, would increase the myosin light chain kinase activity, myosin phosphorylation and force production. In addition, hyper-responsiveness could also result from an increase in Ca 2+ sensitivity which may be mediated by alterations in myosin phosphatase activity (inhibition) or one of its regulators such as Rho-kinase [22, 36] . There are a number of additional factors that could also be part of the problem of AHR, for example the accumulation of more SMCs in the airway wall. This form of sensitization is often countered by steroid therapy but, as mentioned later, the inhibition of K Ca channels to reduce cell proliferation may be a viable alternative.
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Routes of Ca 2+ influx
In view of the excess of extracellular Ca stores via the activation of store-operated channels in the plasma membrane [38, 39] . However, agonists acting on membrane receptors can also initiate Ca 2+ entry by stimulating the production of diacylglycerol or its derivatives to directly activate membrane ion channels called receptor-operated channels (Fig. 1) . Ca 2+ entry via these receptor-operated channels may accompany or precede Ca 2+ influx via store-operated channels [40] [41] [42] [43] . Even though opinions differ with respect to the contribution of receptor-and store-operated Ca 2+ channels to store refilling, both processes have been shown to be necessary to sustain Ca 2+ oscillations in various cell types [39, 44] . Other routes for Ca 2+ entry are voltage-gated Ca 2+ channels and the sodiumcalcium exchanger operating in the reverse-mode [45] . However, the activation of voltage-operated Ca 2+ channels for long time periods requires successive cycles of membrane depolarization and hyper-polarization in order to avoid channel inactivation. Although oscillations in membrane voltage during agonist stimulation have been observed in airway SMCs, the changes in membrane potential are usually inadequate to stimulate the opening of L-type Ca 2+ channels [46] . In addition, the contribution of voltage-gated Ca 2+ channels appears to be minimal because inhibitors of these channels had little effect on agonist-induced SMC contraction or Ca 2+ oscillations [1] or as therapies for AHR [46] . The identities of the channels involved and the mechanism of store-operated channel activation have been long-standing questions since the discovery of store-operated Ca 2+ entry [47] . plasma membrane store-operated channels (Fig. 1) . The fall in Ca 2+ in the internal store leads to the aggregation of STIM1 into punctate structures within the sarcoplasmic reticulum, but close to the plasma membrane, where it can interact with the Orai1 or other store-operated channels [57, 58] . siRNA mediated knockdown of STIM1 significantly reduced store-operated Ca 2+ entry
following Ca 2+ store depletion by histamine but not bradykinin in human airway SMCs [59] . In addition, it has been shown that Orai1 and potentially Orai3 contribute to store-operated channels in these cells [60] . Importantly, Orai1, -2, -3 as well as STIM1 have been found to be expressed in human airway SMCs.
Ca 2+ influx via TRP channels
The molecular identities of all store-and receptor-operated channels in SMCs are not yet fully characterized and the nonselective characteristics of the Ca 2+ influx mechanism suggests the involvement, in addition to Orai1, of other protein channels. In this respect, it appears that the transient receptor potential (TRP) proteins constitute some or parts of these channels [61, 62] . The mammalian TRP protein super-family is comprised of multiple subfamily members [63] . In airway SMCs, several members of the three biggest and most characterized subfamilies (TRPC, TRPM, TRPV) have been proposed to form agonist-activated, cation permeable channels that contribute to Ca 2+ influx to regulate contraction and proliferation [64] . Furthermore, members of all three families are reported to be expressed in human airway SMCs including TRPC1, -3, -4, -5, -6, TRPM4, -7 and TRPV1, -2, -4 [65] [66] [67] [68] [69] . TRP proteins assemble into homo-and/or heteromeric tetramers, generating cation permeable channels [70] which are permeable to a range of mono-and divalent cations. However, permeability differs greatly between the various family members. The TRPCs form largely non-selective cation channels with the selectivity for Na + and Ca 2+ being determined by the specific components of the hetero-multimers [63] . TRP channels are activated by a wide variety of stimuli including mechanical, osmotic and thermal stress and chemical compounds and the expression of some TRP channels may be regulated by growth factors and cytokines [68, 71, 72] . The TRPC family is the subfamily classically associated with store-and receptor-operated Ca 2+ entry. They all appear to be activated by agonist stimulation via the PLC pathway [61] , but there is considerable controversy regarding the relationship of TRPC channels to store-and receptor-operated channels. On the basis of over-expression systems, it has been suggested that the activating mechanism may depend on the expression level [73, 74] . The TRPC1 channel is important for agonist-induced Ca 2+ entry in SMCs. Generally, TRPC1 has been proposed to form a store-operated channel [66, 75] , except in vascular SMCs, where store-operated channels appear to be independent of TRPC1 even though the channel is present and functional [76] . In airway SMCs TRPC1 has been reported to be involved in proliferation and therefore may play a role in airway remodeling [65] . By over-expression of STIM1 in HEK293 cells, STIM1 has been shown to interact with all TRPC proteins except TRPC7, binding directly to TRPC1, 4 and 5, and promoting hetero-multimerization of TRPC3 and 1, and TRPC4 and 6. STIM1 seems necessary for these channels to act as store-operated channels, although it does not appear to be required for channel function per se [58] . This may be
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consistent with the findings in vascular SMCs where STIM1 is required for store-operated channel, but TRPC1 is not [76] .
TRPC3 is also expressed in vascular SMCs where its activation results in Ca 2+ influx and vasoconstriction, whereas its inhibition attenuates depolarization and contraction [77] . The channel is thought to be primarily receptor-operated [78] although in human airway SMCs the expression of TRPC3 channels can be increased by treatment with TNF-a which leads to increased store-operated Ca 2+ entry in response to GPCR agonists such as ACh and bradykinin [68] . Dietrich et al. [79] suggested that TRPC3 channel homo-multimers may be constitutive active in vascular and airway SMCs, whereas channels formed of TRPC3 and TRPC6 hetero-multimers require activation via the PLC pathway. There has been considerable focus on TRPC6 channels in pulmonary vascular SMCs where they are believed to be involved in cell proliferation and may contribute to pulmonary arterial hypertension [80] and hypoxic pulmonary vasoconstriction [81] . Interestingly, TRPC6-deficient mice showed enhanced agonist-induced contraction of aortic rings, a response perhaps explained by a compensating up-regulation of TRPC3. These results highlight some of the complexity in studying the role of these channels [79] . From these findings, it has been proposed in human airway SMCs that TRPC6 serve as a receptor-operated channel, activated by diacylglycerol and its analog 1-oleoyl-2-acetyl-sn-glycerol (OAG) [66] . However, in guinea pig airway SMCs, TRPC6 knock-down did not affect OAG-induced Ca 2+ influx [82] .
In summary, human airway SMCs express several members of the TRPC family, which have been shown to be associated with Ca 2+ influx, contraction and proliferation in other SMC types.
However the functional importance of TRPC as well as Orai proteins in human airway SMCs still needs to be confirmed, although progress towards this goal is hampered by the lack of specific channel agonists and antagonists. In addition, the findings that TRPC proteins can form hetero-multimers and the suggestions that Orai1 proteins can interact with TRPCs [83] raises the possibility that several different store-and receptor-operated channels exist in airway SMCs. These could also be dynamically regulated by factors that change their expression (e.g. cytokines and growth factors) during disease. In view of this association of TRP channels with Ca 2+ influx, contraction and proliferation, TRP channels may be potentially valuable pharmaceutical targets for the treatment of asthma.
Ca 2+ influx via stretch-activated channels
Airway SMCs are exposed to various physical forces such as gravity, compression and rhythmic mechanical strain. Because these forces act on the plasma membrane, Ca 2+ -permeable cation channels, activated by mechanical stretch or stretch-activated channels provide the SMC with the ability to respond to mechanical stimuli [84] [85] [86] [87] (Fig. 1) . Importantly, these Ca 2+ permeable stretch-activated channels occur in human airway SMCs [88] . The mechanisms by which stretch activates these channels are not fully understood, but a direct and indirect mechanism has been proposed [87] . The finding that Gd 3+ blocks stretch-induced Ca 2+ influx in various cells, including airway SMCs, supports the idea of direct activation [88] [89] [90] . Currently, there are two models to explain direct gating of stretch-activated channels; a ''bilayer model'' in which plasma membrane tension itself is sufficient to gate the mechano-sensitive channel and a ''tethered model'' in which mechanical force is transmitted to the ion channel through a linkage formed by the extracellular matrix, integrin proteins and cytoskeleton [86, 87] . For the indirect mechanism, it has been proposed that the activation of PLC or the release of another signaling molecule (e.g. ATP) following application of mechanical stress elicits intracellular Ca 2+ mobilization and subsequent activation of the channels at the plasma membrane [87, 91] . It is also possible that Ca 2+ influx via stretch-activated channels secondly activates voltage-dependent channels by causing membrane depolarization [85, 87] . In human ASM cells, stretch-induced Ca 2+ influx is not blocked by the PLC inhibitor, U-73122, the IP 3 R blocker, xestospongin C, or the voltagegated channel blocker, nifedipine [88] ; these result suggest that Ca
2+
-permeable stretch-activated channels in human airway SMCs are activated directly by stretch rather than indirectly via intracellular messenger production or voltage-dependent channel gating.
TRPV channels: a candidate for stretch-activated channels?
The TRPV subfamily members are activated by a wide variety of stimuli including agonists, heat and changes in osmolarity [61, 63] and there is increasing evidence that a putative mechanosensitive channel is one of the members of the TRPV subfamily [93] [94] [95] . Human airway SMCs express TRPV1, -2 and -4 genes [67, 88] and it appears that TRPV2 and -4 mediate Ca 2+ influx in response to membrane stretch or hypo-osmotic-induced cell swelling [67, 95, 96] . Stretch-induced Ca 2+ influx is inhibited by ruthenium red, a TRPV inhibitor, but not by capsazepine, a TRPV-1 inhibitor [88] . Therefore, TRPV2 and -4 are candidate genes for stretch-activated channels in airway SMCs. However, it should be noted that TRPC6 [97] and TRPM7 [98] TRPV2 is also activated by insulin growth factor (IGF-1) by the insertion of the channel into the cell membrane. Intracellular vesicles, that arise from the Golgi and incorporate the channel, fuse with the plasma membrane upon stimulation with IGF-1 and this process may underlie IGF-1-induced contraction and proliferation of airway SMCs [64] . TRPV2 might also be upregulated in capsaicin-induced asthma and it can be upregulated by growth factors [72] .
Stretch-activated Ca 2+ influx in disease
The lungs are continuously exposed to a mechanically dynamic environment during breathing [99] and excessive strain and pressure occurs in the airway walls during bronchoconstriction in asthmatic patients [100] . Therefore, mechanical stress is likely to have an impact on cellular function in normal and diseased lungs [101, 102] . Indeed, the development [103] , contraction [104, 105] , stiffness [106] [107] [108] , proliferation [109] , migration [110] , organization of the actin cytoskeleton [106, 108, 111, 112] and protein synthesis [113, 114] of airway SMCs are influenced by the mechanical stress. These cellular responses of airway SMCs to mechanical strain are mediated via multiple intracellular pathways including RhoA, myosin light chain kinase, cyclooxygenase (COX), MAP-kinases (ERK1/2 and p38) and various transcription factors [104, 113, [115] [116] [117] [118] . Although the involvement of stretchactivated channels is currently ill-defined, airway SMC contraction or IL-8 production induced by cyclic mechanical strain are significantly inhibited by the stretch-activated channel inhibitor Gd 3+ [104, 113] . Therefore it is important to further characterize stretch-activated channels and their role in airway SMCs as they too may serve as drug targets for the treatment of airway disease [94, 119] . ] i [120, 121] . In addition, the K Ca 1.1 channel, but not the K Ca 3.1 channel, is voltage gated. These properties of high Ca 2+ -sensitivity and voltage-insensitivity allow the K Ca 3.1 channel to open during membrane hyper-polarization when it is likely that K Ca 1.1 is inactive. Such distinct functional properties suggest that these channels may operate during different conditions in the same cell, such as those that occur following a phenotypic alteration in airway SMC. K Ca channels also differ in their sensitivity to inhibitors allowing their different actions to be assessed pharmacologically; K Ca 1.1 channels are inhibited by TEA, iberiotoxin and charybdotoxin whereas K Ca 3.1 channels are inhibited by TRAM-34, clotrimazole, ICA17043 and charybdotoxin [120, 122] .
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The role of K Ca channels in SMC contraction
A Ca 2+ -dependent and voltage-gated outward K + current that is sensitive to charybdotoxin and iberiotoxin is widely found in isolated tracheal SMCs [123] [124] [125] . The properties of this current are consistent with the large conductance K Ca channel (BK or K Ca 1.1); a channel commonly responsible for spontaneous transient outward currents (STOCS) that are associated with 'Ca 2+ sparks' [126] . In vascular SMCs, the Ca 2+ -activation of K Ca 1.1 channels leads to membrane hyper-polarization and the inhibition of voltage-gated L-type Ca 2+ channels. This in turn, reduces the amount of Ca 2+ influx, and thereby decreases SMC tone [127] .
The activation of the K Ca 1.1 channel by physiological (nitric oxide) or therapeutic bronchodilators (isoproterenol) is consistent with this paradigm, although it is not clear how K Ca are activated by these agonists that appear to reduce Ca 2+ by other mechanisms [18] . However, the observations that voltage-gated Ca
2+
-channel inhibitors have no effect on agonist-induced Ca 2+ signaling in airway SMCs [1] , are ineffective bronchodilators [128] and that the deletion of K Ca 1.1 channels in transgenic mice reduced airway contractility [22, 46, 128] all suggest that the contribution of membrane potential to regulation of [Ca 2+ ] i in airway SMCs is minimal. Consequently, the role of K Ca 1.1 in airway SMC contraction remains controversial. Airway SMCs also contain Ca 2+ -activated Cl À channels [7] and these have been found to be responsible for spontaneous transient inward currents (STICS) [126] . The exact role for Ca 2+ -activated Cl À currents in airway SMCs is also unclear, but these currents may enhance Ca 2+ loading of the sarcoplasmic reticulum [129] and influence cell proliferation.
The role of K Ca channels in SMC proliferation
Airway SMCs are adaptable and may adopt a 'synthetic' or 'proliferative' phenotype in chronic asthma [130] . SMC proliferation leads to hyperplasia in asthma and is a feature of isolated human airway SMCs in vitro [131] . This entry into and progression through the cell-cycle requires a careful orchestration of the membrane potential with the [Ca 2+ ] i [132] and this appears to be associated with distinct patterns of K Ca channel expression. Snetkov et al. [133] demonstrated that K Ca 1.1 currents, found in isolated human bronchial SMCs, diminished with in vitro culture and suggested that a reduction in the expression of a major K + channel correlated with a switch to a proliferative phenotype [133, 134] . Similarly, outwardly rectifying currents associated with K Ca channels in proliferating human airway SMCs were relatively insensitive to iberiotoxin, implying a relatively small contribution by K Ca 1.1 [135] . Under these conditions, few cells expressed currents typical of K Ca 3.1 channels, but in response to TGF-b, the majority of cells increased the expression and activity of K Ca 3.1 channels. A loss of K Ca 1.1 channels and gain in K Ca 3.1 channels also occurs when vascular SMCs switch from a contractile to a proliferative phenotype [136, 137] . Thus, the switch from a contractile to a proliferative phenotype by SMCs in response to injury is associated with the replacement of relatively Ca 2+ -insensitive, voltage-gated K Ca channels with voltage-insensitive, but more Ca 2+ -sensitive K Ca channels that may facilitate the regulation of the cell cycle.
The role of K Ca channels in cell-cycle regulation
The idea that the cell cycle is regulated in SMCs by K Ca channels is attractive but, as yet, not well documented. On the other hand there is considerable evidence supporting the idea that a change in membrane potential serves as a critical determinant of cell-cycle progression in other cells. A well-studied example is found with MCF-7 breast cancer cells in which membrane hyperpolarization, mediated by the activation of K + channels, correlates with the progression of cells from the G 0 phase into, and to the end of, the G 1 phase [138, 139] . We review the data from MCF-7 breast cancer cells with the objective of gaining an insight to the mechanisms that may apply to SMCs expressing similar K Ca channels. An arrest of the cell cycle can be induced by the inhibition of K + channels but the particular K + channel involved varies in different cell types. Ouadid et al. [140] also investigating MCF-7 cells found that although the early phases of hyperpolarization (up to mid-G 1 ) were accompanied by increases in K + channels related to the human ether-a-go-go-related gene (K v 10), this channel density and mRNA expression fell later in G 1 despite persistent membrane hyper-polarization. This sustained hyperpolarization was explained by the identification of a clotrimazole and TRAM-34 sensitive, Ca
2+
-activated channel with the characteristics of K Ca 3.1 [140] . The mRNA and currents associated with K Ca 3.1 channel increased throughout G 1 and were maximally elevated in early S-phase. K Ca 3.1 channels have also been implicated in proliferation of mesenchymal cells, vascular SMCs and transformed fibroblasts when stimulated by growth factors [141, 142] . Similarly, inactivation of K Ca 3.1 channels, with inhibitors such as TRAM-34 and clotrimazole, prevented human airway SMC proliferation [135] , SMC re-growth in a model of postangioplasty restenosis [137, 143] 3.5. K + channels as a therapeutic target K Ca 3.1 is expressed by proliferating airway SMCs rather than 'normal' contractile cells [135] and its expression is driven by the pathological mediator TGF-b that is increased in asthmatic airways. Its presence thus characterizes SMCs involved in disease progression making it an attractive therapeutic target in chronic asthma. In addition K Ca 3.1 channels are found in mesenchymal stem cells, epithelial cells and mast cells, all of which contribute to the pathology of chronic asthma [147, 148] . Inhibitors of K Ca 3.1 channels have proven to be safe during clinical trials for sickle cell disease and clinical trials with these inhibitors for the treatment of asthma are being developed [122] .
The role of [Ca
2+
] i in SMC-mediated inflammation
In addition to their contractile and proliferative activities, airway SMCs have also been implicated as a target, as well as a source, of a variety of pro-inflammatory factors and extracellular matrix proteins. Indeed there is evidence that their proliferative and synthetic functions can overlap [149] and that growth factors such as TGF-b, not only induce proliferation, but also induce extracellular matrix deposition [150] . Airway SMCs also respond to cytokines and produce the chemokines CXCL10 (IP-10), in response to interferon (IFN)-g [151, 152] , and IL-8 and eotaxin, in response to IL-4 and IL-13 [153] . Moreover, pro-inflammatory cytokines such as TNF-a, IL-1b and IFN-g induce the expression of multiple chemokines and adhesion molecules in airway SMCs [154] [155] [156] . Thus, airway SMCs can perpetuate the inflammation of asthmatic airways [157] [158] [159] .
There is growing evidence that Ca 2+ signaling is important in the regulation of the production of cytokines and chemokines in other cell types such as T cells [160] . In human adipocytes, secretion of macrophage inhibitory factor (MIF), CD14, macrophage colony-stimulating factor, IL-6 and expression of monocyte chemoattractant protein-1 were all Ca 2+ dependent [161] . IL-1b production by murine peritoneal macrophages [162] and exerciseinduced IL-6 expression by skeletal muscle cells [163] were also regulated by [Ca 2+ ] i . In human bronchial epithelial cells, particulate matter induced IL-1b and IL-8 mRNA expression with an elevation of [Ca 2+ ] i [164] . Additionally, perturbing Ca 2+ homeostasis affects mRNA expression of heme oxygenase-1 in human endothelial cells [165] and nuclear factor kB (NFkB) activation and reactive oxygen species production in monocytes [166] . In airway SMCs, thapsigargin, an inhibitor of SERCA [167] [168] [169] , modulated the differential effect of TNF-a on the production of IL-6 and RANTES (regulated on activation, normal T cell expressed and secreted) [155] . Thapsigargin also reduced TNF-a-induced expression of intercellular adhesion molecule 1 (ICAM-1) by suppressing the activation of NFkB [154] /CaM-dependant protein kinases including CaM kinases I, II, III and IV, myosin light chain kinase and phosphorylase kinase [170] . In NIH 3T3 cells, an increase in [Ca 2+ ] i induced by IFN-g activates CaM kinase II, which in turn, phosphorylates signal transducers and activators of transcription-1 (STAT-1) on serine 727 for maximum transcription activation [171] . In contrast, the inhibition of CaM kinases suppresses IFN-a-induced STAT-1 tyrosine phosphorylation and the activation of macrophages [172] . It would be of interest to determine if Ca 2+ regulates airway SMC STAT-1 activation and cytokine production stimulated by the IFN family.
Summary
Airway SMCs possess a wide array of ion channels which reside in plasma membrane, including receptor-or store-operated channels that may be comprised of a variety of TRP channels, stretch-activated channels, voltage-gated channels and Ca 2+ -dependent K + channels. In addition, SMCs have specialized receptor/channels that reside in the sarcoplasmic reticulum. The activity of these channels significantly contributes to changes in the [Ca 2+ ] i , which, in turn, determines, in the short term, the magnitude of SMC contraction and, in the longer term, SMC proliferation and the production and secretion of pro-inflammatory factors. In an exaggerated state, these cell activities are believed to be collectively expressed as AHR. While changes in ] i are also important. In this respect, the distribution and temporal expression of a variety of ion channels that alter [Ca 2+ ] i provides the necessary plasticity to regulate different SMC functions. As a result, these ion channels form an attractive target for therapeutic approaches for asthma.
